The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Merck & Co.'s 2013 sales performance.
COVAX is the vaccine pillar of the WHO’s ACT Accelerator – a collaborative initiative co-led by Gavi, the World Health Organization (WHO) and the Coalition for Epidemic Preparedness Innovations (CEPI)
AstraZeneca and Merck &Co (MSD) have revealed positive results for their PARP inhibitor Lynparza in the early, adjuvant setting for certain breast cancer patients. ... said Roy Baynes, senior vice president and head of global clinical development, chief
Companies will co-develop molecules for the treatment of immunological and neurodegenerative diseases. ... Lilly will co-develop and commercialise R552 across all indications, including autoimmune and inflammatory diseases.
We have taken additional steps to expand our manufacturing capacity to two billion doses in 2021,” said Ugur Sahin, chief executive officer and co-founder of BioNTech.
Pei-Yong Shim, professor at UTMB and co-author of the study, told Reuters that he believes the Pfizer/BioNTech vaccine is still ‘likely’ to offer protection against the SA variant.
[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]
Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 800 experts delivering world-class...